Impaired consciousness has long been considered the hallmark of epileptic seizures. Both generalized seizures and complex partial seizures are characterized by a multifaceted spectrum of altered ...
Xenon nears a Q3 2026 NDA with strong Phase 3 epilepsy data and a cash runway to 2029. Click here to read an analysis of XENE ...
Aside from standard healthcare, functional medicine aims to improve brain health in the hopes of helping epilepsy patients.
Emerging biomarkers and genetic profiles may help identify patients with high risk for sudden epileptic death.
AN adorable Jack Russell puppy is still seeking a home after winning hearts online. Midge, currently in the care of Hay Animal Rescue, has captured attention through updates about his medical journey, ...
NPCE's RNS adoption, referral growth and AI innovation support expansion, while IGE timing and investments may pressure ...
Background Metformin demonstrates antiepileptogenic (primary prevention) and antiseizure (symptom control) properties in ...
People should be vigilant in preventing mosquito bites, as El Nino, forecast to be strong this year, might increase the risk ...
FDA accepted the new drug application (NDA) for ulixacaltamide in Essential Tremor with a PDUFA target action date of January 29, 2027, and the NDA for relutrigine, with priority review, in SCN2A and ...
XENE's shares climb 22% in six months as azetukalner delivers strong phase III epilepsy data and advances across multiple late-stage studies.
Hikma Pharma launches anti-seizure medication Xcopri in the UAE: London Tuesday, July 7, 2026, 15:00 Hrs [IST] Hikma Pharmaceuticals PLC, the multinational pharmaceutical company, ...
Over the course of nine months, Gemma Louise Latter stole almost 300 pills from Wizard Pharmacy in Carramar including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results